Zobrazeno 1 - 10
of 37
pro vyhledávání: ''
Autor:
Rohit Mehra, Emmanuel S. Antonarakis, Javed Siddiqui, Felix Y. Feng, Costantine Albany, Przemyslaw Twardowski, Bruce Montgomery, Yi-Mi Wu, Karen E. Knudsen, Maha Hussain, Young E. Whang, Mark N. Stein, Dan R. Robinson, Daniel H. Shevrin, Arul M. Chinnaiyan, Megan E.V. Caram, Lakshmi P. Kunju, Walter M. Stadler, Kathleen A. Cooney, Xuhong Cao, Stephanie Daignault-Newton, Robert J. Lonigro, Paul G. Corn, David Smith, Scott A. Tomlins
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 36, iss 10
Purpose To determine whether cotargeting poly (ADP-ribose) polymerase-1 plus androgen receptor is superior to androgen receptor inhibition in metastatic castration-resistant prostate cancer (mCRPC) and whether ETS fusions predict response. Patients a
Autor:
Stephanie Harmon, Glenn Liu, William L. Dahut, Timothy Perk, Robert Jeraj, Christie Lin, Jens Eickhoff, Andrea B. Apolo, Steven M. Larson, John L. Humm, Peter L. Choyke, Michael J. Morris
Publikováno v:
Journal of Clinical Oncology. 35:2829-2837
Purpose [18F]Sodium fluoride (NaF) positron emission tomography (PET)/computed tomography (CT) is a promising radiotracer for quantitative assessment of bone metastases. This study assesses changes in early NaF PET/CT response measures in metastatic
Autor:
Shreyaskumar Patel, Binsheng Zhao, Vadim S. Koshkin, Laurence H. Baker, Denise K. Reinke, Lawrence H. Schwartz, Vanessa Bolejack, Scott M. Schuetze, Rashmi Chugh, Richard L. Wahl, Joo Hyun O
Publikováno v:
Journal of Clinical Oncology. 34:3680-3685
Purpose Despite the rapidly increasing use of [18F]fluorodeoxyglucose (FDG) –positron emission tomography (PET), the comparison of anatomic and functional imaging in the assessment of clinical outcomes has been lacking. In addition, there has not b
Autor:
Andrew M. Evens, Erik Mittra, Mary Jo Lechowicz, Randy D. Gascoyne, Richard I. Fisher, John W. Sweetenham, Craig H. Moskowitz, Heiko Schöder, Bruce D. Cheson, John P. Leonard, Hongli Li, Eric D. Hsi, Brad S. Kahl, Lisa M. Rimsza, Jonathan W. Friedberg, James R. Cook, Michael LeBlanc, Michelle A. Fanale, Oliver W. Press, Ariela Noy, Nancy L. Bartlett, Michael V. Knopp, David J. Straus, Paul M. Barr, Ann S. LaCasce
Publikováno v:
Journal of Clinical Oncology. 34:2020-2027
Purpose Four US National Clinical Trials Network components (Southwest Oncology Group, Cancer and Leukemia Group B/Alliance, Eastern Cooperative Oncology Group, and the AIDS Malignancy Consortium) conducted a phase II Intergroup clinical trial that u
Autor:
Jeffrey E. Gershenwald, Charles R. Scoggins, Kelly M. McMasters, Peter D. Beitsch, B. Scott Davidson, Douglas S. Reintgen, Michael J. Edwards, Arnold J. Stromberg, James S. Goydos, Michael E. Egger, Marshall M. Urist, Stephan Ariyan, Jeffrey J. Sussman, Merrick I. Ross, Lee Hagendoorn, Robert C.G. Martin, R. Dirk Noyes
Publikováno v:
Journal of Clinical Oncology. 34:1079-1086
Purpose The Sunbelt Melanoma Trial is a prospective randomized trial evaluating the role of high-dose interferon alfa-2b therapy (HDI) or completion lymph node dissection (CLND) for patients with melanoma staged by sentinel lymph node (SLN) biopsy. P
Autor:
T. Andrew Lister, Lawrence H. Schwartz, Sally F. Barrington, Bruce D. Cheson, Franco Cavalli, Richard I. Fisher, Emanuele Zucca
Publikováno v:
Cheson, B D, Fisher, R I, Barrington, S F, Cavalli, F, Schwartz, L H, Lister, T A 2014, ' Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma : the Lugano classification ', Journal of Clinical Oncology, vol. 32, no. 27, pp. 3059-3068 . https://doi.org/10.1200/JCO.2013.54.8800
The purpose of this work was to modernize recommendations for evaluation, staging, and response assessment of patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). A workshop was held at the 11th International Conference on Malignant Ly
Autor:
Chaitanya R. Divgi, Robert G. Uzzo, Jian Q. Yu, Constantine Gatsonis, David Y.T. Chen, Jorge A. Carrasquillo, Paul Bevan, Silke Treutner, Steven M. Larson, Roman Bartz, Paul Russo
Publikováno v:
Journal of Clinical Oncology. 31:187-194
Purpose A clinical study to characterize renal masses with positron emission tomography/computed tomography (PET/CT) was undertaken. Patients and Methods This was an open-label multicenter study of iodine-124 (124I) -girentuximab PET/CT in patients w
Autor:
Paolo Veronesi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, Bernardo Bonanni, Giuseppe Viale, Paolo Bruzzi, Alessandra Gennari, Massimiliano Cazzaniga, Harriet Johansson, Fabio Bassi, Valentina Aristarco, Davide Serrano, Clara Varricchio, Giancarlo Pruneri, Viviana Galimberti, Matteo Lazzeroni, Alberto Luini, Andrea Decensi, Maria Stella Trabacca
Publikováno v:
Journal of Clinical Oncology. 30:2593-2600
Purpose Metformin is associated with reduced breast cancer risk in observational studies in patients with diabetes, but clinical evidence for antitumor activity is unclear. The change in Ki-67 between pretreatment biopsy and post-treatment surgical s
Autor:
Lars M. Wagner, Rochelle Bagatell, Clinton F. Stewart, Susan L. Cohn, Cynthia Kretschmar, Stephan D. Voss, Wendy B. London, John M. Maris
Publikováno v:
Journal of Clinical Oncology. 29:208-213
Purpose This phase II study was conducted to determine the response rate associated with use of irinotecan and temozolomide for children with relapsed/refractory neuroblastoma. Patients and Methods Patients with relapsed/refractory neuroblastoma meas
Autor:
Keun Seok Lee, Han Sung Kang, Byoung-Ho Nam, Seeyoun Lee, In Hae Park, Jungsil Ro, Seok Won Kim, So-Youn Jung, Eun-A Kim, Youngmee Kwon
Publikováno v:
Journal of Clinical Oncology. 28:2705-2711
Purpose Goserelin and letrozole in premenopausal patients can result in clinical outcomes comparable to those obtained by letrozole alone in postmenopausal patients with metastatic breast cancer (MBC). Patients and Methods A total of 73 patients with